| Structure |
Chemical Name |
CAS |
MF |
 |
oxidopamine |
1199-18-4 |
C8H11NO3 |
 |
cyprodenate |
15585-86-1 |
C13H25NO2 |
![5-bromo-3-(10-methoxy-1,6-dimethylergolin-8beta-ylmethoxycarbonyl)pyridinium hydrogen [R-(R*,R*)]-tartrate](/CAS/GIF/32222-75-6.gif) |
5-bromo-3-(10-methoxy-1,6-dimethylergolin-8beta-ylmethoxycarbonyl)pyridinium hydrogen [R-(R*,R*)]-tartrate |
32222-75-6 |
C28H32BrN3O9 |
 |
chlorproethazine |
84-01-5 |
C19H23ClN2S |
 |
IMAFEN |
42116-77-8 |
C11H13N3 |
 |
Bepranemab |
2244960-75-4 |
|
 |
Anselamimab |
2414866-63-8 |
|
 |
abecarnil |
111841-85-1 |
C24H24N2O4 |
![Benzeneacetamide, 4-(1-methylethyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-, hydrochloride (1:1)](/CAS/20211123/GIF/2249709-38-2.gif) |
Benzeneacetamide, 4-(1-methylethyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-, hydrochloride (1:1) |
2249709-38-2 |
C20H24ClF3N2O2 |
![Benzoic acid, 4-methyl-, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenyl ester, hydrochloride, hydrate (1:1:2)](/CAS/20211123/GIF/2137075-66-0.gif) |
Benzoic acid, 4-methyl-, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenyl ester, hydrochloride, hydrate (1:1:2) |
2137075-66-0 |
C24H34ClNO4 |
 |
Dibenzepin |
4498-32-2 |
C18H21N3O |
 |
Aptazapine |
71576-41-5 |
C20H23N3O4 |
 |
Declenperone |
63388-37-4 |
C22H24FN3O2 |
 |
Minaprine dihydrochloride |
25953-17-7 |
C17H24Cl2N4O |
 |
bapineuzumab |
648895-38-9 |
|
 |
3-(2-Chloro-9H-thioxanthen-9-ylidene)-N,N-dimethyl-1-propanamine acetate |
58889-16-0 |
C18H18ClNS.C2H4O2 |
 |
SC-27123 |
51481-67-5 |
C20H24NO4P |
 |
Imipraminoxide |
19864-71-2 |
|
 |
Bornaprine |
20448-86-6 |
C21H31NO2 |
 |
Tezampanel hydrate |
317819-68-4 |
C13H23N5O3 |
 |
Alonimide |
2897-83-8 |
C14H13NO3 |
 |
Azipramine |
57529-83-6 |
C26H27ClN2 |
 |
Butoctamide |
32838-28-1 |
C16H29NO5 |
 |
Clazolam |
7492-29-7 |
C18H17ClN2O |
 |
Pancopride |
121650-80-4 |
C18H24ClN3O2 |
 |
Thiazesim |
3122-01-8 |
C19H23ClN2OS |
 |
Uldazepam |
28546-58-9 |
C18H15Cl2N3O |
 |
Xaliproden |
135354-02-8 |
C24H22F3N |
![Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, phenylcarbamate (ester), (3aR,8aS)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) (9CI)](/CAS/20211123/GIF/865795-23-9.gif) |
Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, phenylcarbamate (ester), (3aR,8aS)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) (9CI) |
865795-23-9 |
C24H29N3O8 |
![N,N′-[(2S)-2-[(Phosphonooxy)methoxy]bicyclo[2.2.2]octane-1,4-diyl]bis[2-(4-chloro-3-fluorophenoxy)acetamide]](/CAS/20210305/GIF/2415715-84-1.gif) |
N,N′-[(2S)-2-[(Phosphonooxy)methoxy]bicyclo[2.2.2]octane-1,4-diyl]bis[2-(4-chloro-3-fluorophenoxy)acetamide] |
2415715-84-1 |
C25H27Cl2F2N2O9P |
 |
Vanutide cridificar |
886584-10-7 |
|
 |
DAU 6215 |
123258-84-4 |
C16H20N4O2 |
 |
mazapertine succinate |
134208-18-7 |
C30H41N3O6 |
 |
Pegorgotein |
155773-57-2 |
C7H13NO4 |
 |
Rolicyprine |
2829-19-8 |
C14H16N2O2 |
 |
Research Grade Usilnetug |
2770861-19-1 |
|
![2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-morpholin-4-yl-pyridin-3-yl]propanamide](/CAS/GIF/290296-68-3.gif) |
2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-morpholin-4-yl-pyridin-3-yl]propanamide |
290296-68-3 |
C29H29F6N3O2 |
 |
Unii-5p71E6yo9h |
195068-07-6 |
C22H22ClFN2O |
 |
Adrogolide |
166591-11-3 |
C22H26ClNO4S |
 |
(S)-3-(2-aMino-3-MethylbutanaMido)propane-1-sulfonic acid |
1034190-08-3 |
C8H18N2O4S |
 |
Flesinoxan |
98206-10-1 |
C22H26FN3O4 |
 |
perampanel 3/4 hydrate |
1571982-04-1 |
C23H17N3O2 |
![4-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE, HYDROCHLORIDE](/CAS/20180629/GIF/882737-42-0.gif) |
4-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE, HYDROCHLORIDE |
882737-42-0 |
C15H24ClNO2S |
![N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxopyrrolidin-3-yl]acetamide](/CAS/20180529/GIF/676479-06-4.gif) |
N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxopyrrolidin-3-yl]acetamide |
676479-06-4 |
C19H19FN2O3 |
 |
PCC0104005 |
1708960-04-6 |
C22H26Cl3N3O3 |
 |
(R)-2-PROPYLOCTANOIC ACID |
185517-21-9 |
C11H22O2 |
 |
Nemorexant |
1505484-82-1 |
C23H23ClN6O2 |
 |
Elenbecestat(E2609) |
1388651-30-6 |
C19H18F3N5O2S |
 |
S(+)-METHADONE HYDROCHLORIDE INACTIVE EN ANTIOMER O |
5653-80-5 |
C21H27NO |
![TERT-BUTYL-BICYCLO [2.2.2]](/CAS/GIF/70636-86-1.gif) |
TERT-BUTYL-BICYCLO [2.2.2] |
70636-86-1 |
C8H15O3PS |
 |
CLORGYLINE |
17780-72-2 |
C13H15Cl2NO |
 |
4-(2-(2,4,6-Trifluorophenoxymethyl)phenyl)piperidine |
1227056-84-9 |
C18H18F3NO |
 |
9-Anthracenepropanamine, 9,10-dihydro-N,N,10-trimethyl-2-(trifluoromethyl)-, hydrochloride (1:1), (9R,10S)-rel- |
35764-29-5 |
C21H25ClF3N |
![2,3,3A,4,5,6-HEXAHYDRO-8-METHYL-1H-PYRAZINO[3,2,1-J,K]CARBAZOLE MESYLATE](/CAS/GIF/60762-57-4.gif) |
2,3,3A,4,5,6-HEXAHYDRO-8-METHYL-1H-PYRAZINO[3,2,1-J,K]CARBAZOLE MESYLATE |
60762-57-4 |
C15H18N2 |
 |
Abacavir acetate |
916918-80-4 |
C24H31NO3 |
 |
Dihydrochloride monohydrate |
60789-62-0 |
C28H40Cl2N4O2 |
 |
Dothiepin |
113-53-1 |
C19H21NS |
 |
PROTRIPTYLINE |
438-60-8 |
C19H21N |
 |
Dezamizumab |
1662664-56-3 |
|
 |
Gosuranemab |
1788032-39-2 |
|
![(S)-3-phenyl-1'-(phenylmethyl)[3,4'-bipiperidine]-2,6-dione monohydrochloride](/CAS/GIF/21888-96-0.gif) |
(S)-3-phenyl-1'-(phenylmethyl)[3,4'-bipiperidine]-2,6-dione monohydrochloride |
21888-96-0 |
C23H27ClN2O2 |
![10-[(1-methyl-3-piperidyl)methyl]-10H-phenothiazine monoacetate](/CAS/GIF/24360-97-2.gif) |
10-[(1-methyl-3-piperidyl)methyl]-10H-phenothiazine monoacetate |
24360-97-2 |
C21H26N2O2S |
 |
captodiame |
486-17-9 |
C21H29NS2 |
 |
4-(acetamido)benzoic acid, compound with 2-(dimethylamino)ethanol (1:1) |
3635-74-3 |
C9H9NO3.C4H11NO |
![Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, benzenesulfonate, hydrate (1:1:1)](/CAS/20211123/GIF/609345-59-7.gif) |
Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, benzenesulfonate, hydrate (1:1:1) |
609345-59-7 |
C23H33NO5S |
![1,3-BENZENEDISULFONIC ACID, 4-[[(1,1-DIMETHYLETHYL)OXIDOIMINO]METHYL]-,DISODIUM SALT](/CAS/GIF/168021-79-2.gif) |
1,3-BENZENEDISULFONIC ACID, 4-[[(1,1-DIMETHYLETHYL)OXIDOIMINO]METHYL]-,DISODIUM SALT |
168021-79-2 |
C11H14NNa2O7S2 |
 |
Troxypyrrolium tosilate |
6443-40-9 |
C26H32N2O5S |
 |
Azepindole |
26304-61-0 |
C12H14N2 |
 |
Bentazepam |
29462-18-8 |
C17H16N2OS |
 |
Brofaromine |
63638-91-5 |
C14H16BrNO2 |
 |
Butriptyline |
35941-65-2 |
C21H27N |
 |
Clofluperol |
17230-87-4 |
C22H23Cl2F4NO2 |
 |
Elantrine |
1232-85-5 |
C20H24N2 |
 |
Fengab |
80018-06-0 |
C17H17Cl2NO |
 |
Flubanilate |
967-48-6 |
C14H19F3N2O2.ClH |
 |
Modaline |
2856-75-9 |
C10H17N3O4S |
 |
Nabazenil |
58019-65-1 |
C35H55NO3 |
 |
Pentabamate |
5667-70-9 |
C8H16N2O4 |
 |
Suritozole |
110623-33-1 |
C10H10FN3S |
 |
Tameridone |
102144-78-5 |
C22H26N6O2 |
![2,4(1H,3H)-Pyrimidinedione, 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-, (-)-](/CAS/20211123/GIF/1643489-35-3.gif) |
2,4(1H,3H)-Pyrimidinedione, 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-, (-)- |
1643489-35-3 |
C19H17F2N3O4 |
 |
Research Grade Trontinemab (DHC12508) |
2568868-35-7 |
|
 |
NMD670 |
2354321-33-6 |
C12H10BrNO4 |
 |
Givosiran sodium |
1639325-44-2 |
|
 |
COTININEFUMARATE |
5695-98-7 |
C14H16N2O5 |
![Ethanone, 2-(3,5-dichloro-1-methyl-1H-indazol-4-yl)-1-[(1S,3R)-3,4-dihydro-3-(hydroxymethyl)-5-(1-hydroxy-1-methylethyl)-1-methyl-2(1H)-isoquinolinyl]-](/CAS/20240320/GIF/2576359-31-2.gif) |
Ethanone, 2-(3,5-dichloro-1-methyl-1H-indazol-4-yl)-1-[(1S,3R)-3,4-dihydro-3-(hydroxymethyl)-5-(1-hydroxy-1-methylethyl)-1-methyl-2(1H)-isoquinolinyl]- |
2576359-31-2 |
C24H27Cl2N3O3 |
 |
N-(2-Aminoethyl)-5-chlor-2-pyridincarboxamid-hydrochlorid |
103878-83-7 |
C8H10ClN3O.HCl |
 |
2-(2-CHLOROPHENYL)-2-HYDROXYETHYL CARBAMATE |
194085-75-1 |
C813CH8D2Cl15NO3 |
![Quinoline, 2-[[4-[1-methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-](/CAS/GIF/898562-94-2.gif) |
Quinoline, 2-[[4-[1-methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]- |
898562-94-2 |
C25H20N4O |
 |
Tioperidone hydrochloride |
52618-68-5 |
C25H33ClN4O2S |
 |
Daledalin tosylate |
23226-37-1 |
C26H32N2O3S |
 |
BL-3912A |
52663-86-2 |
C13H22ClNO2 |
 |
Ketipramine fumarate |
17243-32-2 |
C23H26N2O5 |
 |
Truxal (tn) |
861959-57-1 |
C18H18ClNS.C6H8O7 |
 |
lisdexamfetamine |
608137-32-2 |
C15H25N3O |
 |
Octanoic acid, 3-aMino-5-Methyl-, hydrochloride (1:1), (3S,5R)- |
610300-00-0 |
C9H20ClNO2 |
 |
PeraMpanel |
380917-97-5 |
C23H15N3O |
 |
PAZ 417 |
481629-87-2 |
C28H27NO3 |
 |
Pramiracetam hydrochloride |
75733-50-5 |
C14H27N3O2.ClH |
![5-((7-(Trifluoromethyl)-5-(4-(trifluoromethyl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)ethynyl)pyridin-2-amine](/CAS/20180629/GIF/911115-16-7.gif) |
5-((7-(Trifluoromethyl)-5-(4-(trifluoromethyl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)ethynyl)pyridin-2-amine |
911115-16-7 |
C21H11F6N5 |